---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285573935.md"
description: "Aurinia Pharmaceuticals shares are trading lower. The company reported Q1 financial results and affirmed FY26 sales guidance below estimates."
datetime: "2026-05-07T14:38:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285573935.md)
  - [en](https://longbridge.com/en/news/285573935.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285573935.md)
---

# 

Aurinia Pharmaceuticals shares are trading lower. The company reported Q1 financial results and affirmed FY26 sales guidance below estimates.

### Related Stocks

- [AUPH.US](https://longbridge.com/en/quote/AUPH.US.md)

## Related News & Research

- [Aurinia Pharmaceuticals Completes Acquisition of Kezar Life Sciences](https://longbridge.com/en/news/285957581.md)
- [What Madrigal Pharmaceuticals (MDGL)'s Wider Q1 Losses and Rezdiffra Revenue Momentum Mean For Shareholders](https://longbridge.com/en/news/286674743.md)
- [Ultragenyx Shareholders Approve Incentive Plan, Elect Directors](https://longbridge.com/en/news/286809118.md)
- [Eli Lilly Among Petitioners Denied Certiorari as Supreme Court Rejects Multiple Appeals](https://longbridge.com/en/news/286789989.md)
- [Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital | QNTM Stock News](https://longbridge.com/en/news/286727225.md)